These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 23143830)

  • 1. [Including or excluding data: intention-to-treat and completer analyses].
    Böhnke JR; Lutz W
    Psychother Psychosom Med Psychol; 2012 Nov; 62(11):429. PubMed ID: 23143830
    [No Abstract]   [Full Text] [Related]  

  • 2. Per-Protocol Analyses of Pragmatic Trials.
    Hernán MA; Robins JM
    N Engl J Med; 2017 Oct; 377(14):1391-1398. PubMed ID: 28976864
    [No Abstract]   [Full Text] [Related]  

  • 3. Intention-to-treat analysis: protecting the integrity of randomization.
    Mahaniah KJ; Rao G
    J Fam Pract; 2004 Aug; 53(8):644. PubMed ID: 15298838
    [No Abstract]   [Full Text] [Related]  

  • 4. Intention-to-treat in randomized controlled trials: recommendations for a total trial strategy.
    Polit DF; Gillespie BM
    Res Nurs Health; 2010 Aug; 33(4):355-68. PubMed ID: 20645423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Making sense of intention-to-treat.
    Sainani KL
    PM R; 2010 Mar; 2(3):209-13. PubMed ID: 20359686
    [No Abstract]   [Full Text] [Related]  

  • 6. Compliance in clinical trials: impact on design, analysis and interpretation.
    Pledger GW
    Epilepsy Res Suppl; 1988; 1():125-33. PubMed ID: 3072187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of non-compliance on intent-to-treat analysis of equivalence trials.
    Sheng D; Kim MY
    Stat Med; 2006 Apr; 25(7):1183-99. PubMed ID: 16220491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intention-to-treat Analysis Controls the Bias When Suffer From Noncompliance and Missing Outcomes in Randomized Controlled Trial Study.
    Chang W; Wei Y; Xu J; Chang W; Wei Y; Zhong Y; Xu J; Zhong Y; Zhao N
    Ann Surg; 2017 Dec; 266(6):e78-e79. PubMed ID: 27049767
    [No Abstract]   [Full Text] [Related]  

  • 9. Adjusting for Nonadherence or Stopping Treatments in Randomized Clinical Trials.
    Adler AI; Latimer NR
    JAMA; 2021 May; 325(20):2110-2111. PubMed ID: 34032845
    [No Abstract]   [Full Text] [Related]  

  • 10. The intention to treat principle, and the potential impact of excluding data from the analysis of clinical trial data.
    Sempos CT; Picciano MF
    J Nutr; 2009 Jun; 139(6):1204; author reply 1205-6. PubMed ID: 19403721
    [No Abstract]   [Full Text] [Related]  

  • 11. Challenges of Non-Intention-to-Treat Analyses.
    DeMets DL; Cook T
    JAMA; 2019 Jan; 321(2):145-146. PubMed ID: 30556836
    [No Abstract]   [Full Text] [Related]  

  • 12. Intention to treat analysis and per protocol analysis: complementary information.
    Prescrire Int; 2012 Dec; 21(133):304-6. PubMed ID: 23373104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitivity analysis of intention-to-treat estimates when withdrawals are related to unobserved compliance status.
    Salim A; Mackinnon A; Griffiths K
    Stat Med; 2008 Apr; 27(8):1164-79. PubMed ID: 17724782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The intention-to-treat approach in randomized controlled trials: are authors saying what they do and doing what they say?
    Gravel J; Opatrny L; Shapiro S
    Clin Trials; 2007; 4(4):350-6. PubMed ID: 17848496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparisons of methods for analysis of repeated binary responses with missing data.
    Frank Liu G; Zhan X
    J Biopharm Stat; 2011 May; 21(3):371-92. PubMed ID: 21442514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysing non-compliance in clinical trials: ethical imperative or mission impossible?
    Goetghebeur EJ; Shapiro SH
    Stat Med; 1996 Dec; 15(24):2813-26. PubMed ID: 8981688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The implications of non-compliance: Randomised controlled trials: the intention-to-treat principle.
    Platt AC; Turner EL
    BJOG; 2019 Oct; 126(11):1337. PubMed ID: 31222882
    [No Abstract]   [Full Text] [Related]  

  • 18. Intention-to-treat analysis: who is in? Who is out?
    Kruse RL; Alper BS; Reust C; Stevermer JJ; Shannon S; Williams RH
    J Fam Pract; 2002 Nov; 51(11):969-71. PubMed ID: 12485553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statistical analysis of COPD exacerbations.
    Keene ON; Calverley PM; Jones PW; Vestbo J; Anderson JA
    Eur Respir J; 2008 Nov; 32(5):1421-2. PubMed ID: 18978151
    [No Abstract]   [Full Text] [Related]  

  • 20. Editorial: Estimands in clinical trials - a challenge to intention to treat?
    Day S
    Stat Med; 2017 Jan; 36(1):3-4. PubMed ID: 27917553
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.